J&J Shrugs Off Trump Pharma Tariff Threat and Boosts Outlook (4)

Johnson & Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as the pharmaceutical industry faces the dual threats of tariffs and a crackdown on drug pricing.

J&J’s strong second quarter comes as President Donald Trump floats the idea of levies on the sector. On Tuesday night, he said tariffs on drugs could “probably” come at the end of the month, starting low and working their way up.

A week earlier, Trump told reporters he would impose tariffs as high as 200% on drug companies if they don’t shift more of their manufacturing ...